T3A-10224-07863
2 vaccinations
4 coded responses
8 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-01-14
Survey response — day 0, dose 1MedDRA: Paraesthesia — Feeling: Good · Site: PainFree text: Tingling faceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-16
- 2021-01-18
- 2021-01-19
-
2021-02-04
Dose 2 — Pfizer-BioNTech
-
2021-02-04
Survey response — day 0, dose 2MedDRA: Hypoaesthesia, Paraesthesia — Feeling: Good · Site: PainFree text: Numbness/tingles in faceMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-05
Survey response — 6 months, dose 2MedDRA: Abortion spontaneous — Feeling: GoodFree text: Two miscarriagesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-04
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Additional miscarriage (4th since shot)MedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-07
-
2022-03-11
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-04 | Successful 2022-03-11 |
Participant prefers to complete VAERS report online |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Tingling face
Release 3 — day 0, dose 2
Systemic reaction (other): Numbness/tingles in face
Release 9 — 6 months, dose 2
Symptoms: Two miscarriages
Release 11 — 12 months, dose 2
Symptoms: Additional miscarriage (4th since shot)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | · | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release